Passage Bio Inc (PASG) — Defensive Interval Ratio
Passage Bio Inc (PASG) has a Defensive Interval Ratio of 0 days as of September 2025. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $60.95K/day. See PASG working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Passage Bio Inc Defensive Interval Ratio (2020–2024)
This chart shows how Passage Bio Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See how leveraged is Passage Bio Inc's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Passage Bio Inc (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Passage Bio Inc from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Passage Bio Inc (PASG) total market value.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 739 days | $39.18 Million | $53.05K/day | $- | $39.18 Million | ▼ -1329 days |
| 2023 | 2068 days | $92.58 Million | $44.77K/day | $- | $92.58 Million | ▼ -1100 days |
| 2022 | 3168 days | $159.28 Million | $50.28K/day | $- | $155.01 Million | ▲ +780 days |
| 2021 | 2388 days | $193.01 Million | $80.82K/day | $- | $186.81 Million | ▼ -677 days |
| 2020 | 3066 days | $177.84 Million | $58.01K/day | $- | $169.81 Million | — |